This is the first meta-analysis focused on the association between SIRT3 expression and patient clinicopathological outcomes including survival, cancer/non-cancer tissues, lymph node metastasis, pathological differentiation, tumor stage, tumor size, and gender. This evidence concerns the gene SIRT3 and metastatic malignant neoplasm in the lymph nodes.